Structure-function relationships in serine protease-bovine pancreatic trypsin inhibitor interaction

Area of Science:

• Biochemistry
• Structural Biology
• Protein Engineering

Background:

• Serine proteases are crucial enzymes involved in numerous physiological processes.
• Protease inhibitors regulate protease activity, making them important therapeutic targets.
• Understanding the molecular basis of protease-inhibitor interactions is key to drug design.

Purpose of the Study:

• To elucidate the structure-function relationships governing the interaction between Bowman-Birk protease inhibitor (BPTI) and serine proteases.
• To investigate the impact of specific mutations within the BPTI binding loop on protease inhibition.
• To characterize the biophysical and structural consequences of these mutations.

Main Methods:

• Site-directed mutagenesis was employed to generate BPTI variants with modifications at four key positions in the protease binding loop.
• Association constants were determined using techniques such as surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC).
• Stability parameters were assessed through circular dichroism (CD) spectroscopy or differential scanning calorimetry (DSC).
• Complex structures of BPTI variants with cognate serine proteases were determined using X-ray crystallography or cryo-electron microscopy (cryo-EM).

Main Results:

• Mutagenesis revealed specific amino acid residues critical for high-affinity binding to serine proteases.
• Changes in association constants indicated altered binding affinities for the engineered BPTI variants.
• Stability assays showed varying degrees of impact on inhibitor stability due to mutations.
• Structural analyses provided atomic-level insights into how mutations affect the BPTI-protease complex conformation and interaction interface.

Conclusions:

• The study successfully identified key residues in the BPTI binding loop that dictate the strength and specificity of serine protease inhibition.
• The findings provide a detailed molecular understanding of structure-function relationships in protease-inhibitor interactions.
• This knowledge can guide the rational design of novel protease inhibitors with improved efficacy and specificity for therapeutic applications.